In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lil’ Drug Store

This article was originally published in The Rose Sheet

Executive Summary

Firm refers wholesalers and retailers to its Convenience Profitability Program, a health and beauty-care (HBC) category management initiative to increase sales of convenience-sized health and beauty items, according to Oct. 15 release. "Currently, HBC is underdeveloped and represents only a small percentage of in-store sales. ... The section is highly SKU-intensive, has many subcategories and a history of complicated [legislation]. These challenges are worth reviewing though, as [HBC] items contribute high margins," release notes. Program promises to make the HBC section of a store easy to run by providing account-specific plan-o-gram development and customer-specific sales tools, among other services. "Wholesalers and retailers that have implemented the convenience profitability program have increased distribution of top-moving products and reduced the total number of SKUs carried by up to 50 percent," Paul Rossberger, VP-sales and marketing for Lil' Drug Store Products, says...



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts